A new agent, blue and radioactive, for sentinel node detection

Annals of Surgical Oncology

Volumn 10, Issue 3, 2003, Pages 323-329

  El Tamer, Mahmoud ^a   Saouaf, Rola ^a   Wang, Ted ^a   Fawwaz, Rashid ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Isosulfan blue; Phthalocyanine; Radiotracer; Sentinel node

Indexed keywords

PHTHALOCYANINE DERIVATIVE; PHTHALOCYANINE TETRASULFONIC ACID TC 99M; TRACER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; INDOLE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M TETRASULFOPHTHALOCYANINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOPLASM; DERMIS; HINDLIMB; HISTOLOGY; INGUINAL REGION; INJECTION SITE; LYMPH NODE; NONHUMAN; RABBIT; RADIOACTIVITY; SENTINEL LYMPH NODE BIOPSY; STAINING; ANIMAL; LYMPH NODE METASTASIS; METHODOLOGY; SCINTISCANNING; TISSUE DISTRIBUTION;

ANIMALS; INDOLES; LYMPHATIC METASTASIS; ORGANOTECHNETIUM COMPOUNDS; RABBITS; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TISSUE DISTRIBUTION;

EID: 0038809971     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2003.03.087     Document Type: Article

References (47)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
2. Alex JC, Weaver DL, Fairbank JT, et al. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 1993; 2:303-8.
3. Krag DN, Meijer SJ, Weaver DL, et al. Minimal access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-8.
4. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I and II melanoma. J Clin Oncol 1998;16:2253-60.
5. Beitsch PD, Clifford E, Whitworth P, Abarca A. Improved lymphatic mapping technique for breast cancer. Breast J 2001;7:219-23.
6. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-7.
7. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 1998;339: 941-6.
8. Cody HS III. Current surgical management of breast cancer. Curr Opin Obstet Gynecol 2002;14:45-52.
9. Singletary SE. New approaches to surgery for breast cancer. Endocr Relat Cancer 2001;8:265-86.
10. Haigh PI, Brennan MB, Giuliano AE. Surgery for diagnosis and treatment. Sentinel lymph node biopsy in breast cancer. Cancer Control 1999;6:301-6.
11. Reintgen D. Expanding indications for lymphatic mapping and sentinel lymph node biopsy in the breast cancer population. Ann Surg Oncol 2001;8:687.
12. Ross MI. Sentinel node dissection in early-stage breast cancer: ongoing prospective randomized trials in the USA. Ann Surg Oncol 2001;8(9 Suppl):77S-81S.
13. Giuliano AE. Current status of sentinel lymphadenectomy in breast cancer. Ann Surg Oncol 2001:8(9 Suppl):52S-55S.
14. Fraile M, Rull M, Julian FJ, et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity (erratum appears in Ann Oncol 2000;11:1619). Ann Oncol 2000;11:701-5.
15. Saha S, Bilchik A, Wiese D, et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique - a multicenter trial. Ann Surg Oncol 2001;8(9 Suppl):94S-98S.
16. Esser S, Reilly WT, Riley LB, Eyvazzadeh C, Arcona S. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum 2001;44:850-4; discussion 854-6.
17. Paramo JC, Summerall J, Wilson C, et al. Intraoperative sentinel lymph node mapping in patients with colon cancer. Am J Surg 2001;182:40-3.
18. Ota DM, Lin K. Lymphatic mapping and sentinel node identification for colorectal cancer. Swiss Surg 2001;7:252-5.
19. Bendavid Y, Latulippe JF, Younan RJ, et al. Phase I study on sentinel lymph node mapping in colon cancer: a preliminary report. J Surg Oncol Suppl 2002;79:81-4: discussion 85.
20. Yasuda S, Shimada H, Ogoshi K, et al. Preliminary study for sentinel lymph node identification with Tc-99m tin colloid in patients with esophageal or gastric cancer. Tokai J Exp Clin Med 2001;26:15-8.
21. Thorn M. Lymphatic mapping and sentinel node biopsy: is the method applicable to patients with colorectal and gastric cancer? Eur J Surg 2000;166:755-8.
22. Hiratsuka M, Miyashiro I, Ishikawa O, et al. Application of sentinel node biopsy to gastric cancer surgery. Surgery 2001;129:335-40.
23. Kitagawa Y, Kubota T, Otani Y, et al. Clinical significance of sentinel node navigation surgery in the treatment of early gastric cancer. Nippon Geka Gakkai Zasshi 2001;102:753-7.
24. Wawroschek F, Vogt H, Weckermann D, Wagner T, Hamm M, Harzmann R. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 2001;166:1715-9.
25. Arch-Ferrer J, Velazquez D, Fajardo R, et al. Accuracy of sentinel node in papillary thyroid carcinoma. Surgery 2001;130:907-13.
26. Dixon E, McKinnon JG, Pasieka JL. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg 2000;24:1396-401.
27. Stoeckli SJ, Pfaltz M, Steinert H, Schmid S. Histopathological features of occult metastasis detected by sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma. Laryngoscope 2002;112:111-5.
28. Lim RB, Wong JH. Sentinel lymphadenectomy in gynecologic and solid malignancies other than melanoma and breast cancer. Surg Clin North Am 2000;80:1787-98.
29. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-8.
30. Bergkvist L, Frisell J, Liljegren G, Celebioglu F, Damm S, Thorn M. Multicenter study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 2001;88:1644-8.
31. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-9.
32. Albertini JJ, Lyman GH, Cox CE, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
33. McMasters KM, Turtle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. Clin Oncol 2000;18:2560-6.
34. Cox CE. Lymphatic mapping in breast cancer: combination technique. Ann Surg Oncol 2001;8(9 Suppl):67S-70S.
35. Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001;193:473-8.
36. Noguchi M. Sentinel lymph node biopsy and breast cancer. Br J Surg 2002;89:21-34.
37. McCarter MD, Yeung H, Yeh S, Fey J, Borgen PI, Cody HS III. Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection. Ann Surg Oncol 2001;8:682-6.
38. 99mTc-labeled sulfur colloid. Ann Surg Oncol 2001;8: 821-7.
39. Nathanson SD, Wachna DL, Gilman D, Karvelis K, Havstad S, Ferrara J. Pathways of lymphatic drainage from the breast. Ann Surg Oncol 2001;8:837-43.
40. Cox CE, Haddad F, Bass S, et al. Lymphatic mapping in the treatment of breast cancer. Oncology 1998;12:1283-92.
41. Wong DW. A simple chemical method of labeling hematoporphyrin derivative with Tc-99m. J Label Compd Radiopharm 1983;20: 351-61.
42. Rousseau JR, Autenreith D, Van Lier JE. Tissue distribution and tumor uptake of Tc-99m tetrasulfophthalocyanine. Int J Appl Radiat Isot 1983;34:571-9.
43. 109Pd- porphyrin complexes for selective lymphatic ablation. J Nucl Med 1971;12:231-6.
44. 109Pd-protoporphyrin. J Nucl Med 1974;15:997-1002.
45. Office of the Federal Register, US National Archives and Records Administration. Code of Federal Regulation. Food and Drugs, Vol 21. Washington, DC: 1985:315.
46. Bigelow NM, Perkins MA. Phthalocyanine pigments. In: Lubs HA, ed. The Chemistry of Synthetic Dyes and Pigments. New York: Reinhold, 1955:577-605.
47. Uspenskii LV, Chistov LV, Kogan EA, et al. Endobronchial laser therapy in complex preoperative preparation of patients with lung diseases. Khirurgiia 2000;2:38-40.